Product
Ambisome
1 clinical trial
1 indication
Indication
Chronic Pulmonary AspergillosisClinical trial
Therapeutic Efficacy Comparison of a Six-month Treatment by Itraconazole and Nebulised Ambisome® Versus Treatment by Itraconazole Alone in Non- or Mildly- Immunocompromised Patients With Chronic Pulmonary Aspergillosis: a Prospective, Randomized, Single Blind Study, (Single Aspergilloma Excluded)Status: Recruiting, Estimated PCD: 2027-06-01